The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Treprostinil Tillomed 5 mg/ml solution for infusion

Tillomed Pharma GmbHPA22720/011/003

Main Information

Trade NameTreprostinil Tillomed 5 mg/ml solution for infusion
Active SubstancesTreprostinil
Dosage FormSolution for infusion
Licence HolderTillomed Pharma GmbH
Licence NumberPA22720/011/003

Group Information

ATC CodeB01AC21 treprostinil


License statusAuthorised
Licence Issued30/09/2022
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal products subject to restricted medical prescription (see Summary of Product Characteristics, section 4.2).
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Educational Materials - HCP

Educational Materials - Patient

« Back